DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/7r5gvv/australian) has announced the addition of the "Australian Diabetes Management Devices Market, 2007 - 2020" report to their offering.
The Australian Diabetes Management and Diabetes Diagnostic Devices market jumped by $46 million between 2005 and 2013
The market comprises continuous glucose monitors (CGM), self-monitoring blood glucose (SMBG), manual insulin delivery products, glucose test strips, lancets, syringes, insulin pens and insulin pumps. The growth is driven by the high prevalence of diabetes, acceptance and proliferation of advanced patient compliant technologies, increased reimbursement of devices and government subsidy on consumables. Especially, continuous glucose monitors (CGM), self-monitoring blood glucose (SMBG) and manual insulin delivery products exhibited significant market growth.
The prevalence of diabetes in Australia has skyrocketed three times to 4.2% over the last 25 years. Around 1 million people in country suffer from diabetes and around 2 million have pre-diabetes. Of these, 11% have type 1 diabetes, 87% have type 2 diabetes and 2% women have gestational diabetes. We estimate that approximately 3.4 million citizens will suffer from diabetes by 2030. This high progression rates in diabetes can be attributed to the growth in elderly population, increased life expectancy, obesity, sedentary life style, unhealthy diet and high stress levels. Further, factors like smoking and physical inactivity have led to increased prevalence of both the types of diabetes in young people.
Key Topics Covered:
1. Charts & Tables
2. Australia Market for Diabetes Management Devices (2007-2020)
3. Australia Market for Blood Glucose Monitoring Systems (2007-2020)
4. Australia Market for Insulin Delivery Devices (2007-2020)
5. Recent Global Developments
6. Company and Product Profiles
ARKRAY Inc.
Abbott Laboratories
Animas Corporation
Bayer HealthCare AG
Becton
Dickinson and Company
Eli Lilly and Company
F. Hoffmann-La Roche AG
LifeScan Inc.
Medtronic Inc.
Novo Nordisk A/S
Sanofi S.A.
Smiths Medical
Terumo Corporation
For more information visit http://www.researchandmarkets.com/research/7r5gvv/australian